title: Breast cancer subtypes: morphologic and biologic characterization.
abstract: Advances in basic science, technology and translational research have created a revolution in breast cancer diagnosis and therapy. Researchers' discoveries of genes defining variability in response to therapy and heterogeneity in clinical presentations and tumor biology are the foundation of the path to personalized medicine. The success of personalized breast cancer care depends on access to pertinent clinical information and risk factors, optimal imaging findings, well-established morphologic features, and traditional and contemporary prognostic/predictive testing. The integration of these entities provides an opportunity to identify patients who can benefit from specific therapies, and demonstrates the link between breast cancer subtypes and their association with different tumor biology. It is critical to recognize specific types of breast cancer in individual patients and design optimal personalized therapy. This article will highlight the roles of morphologic features and established tumor biomarkers on patient outcome.
authors.affiliation: Department of Pathology & Laboratory Medicine, University of Florida College of Medicine - Jacksonville, UF Health Breast Center, UF Health Jacksonville, 655 W. 8th Street, Box C-505, Jacksonville, FL 32209, USA.
authors.forename: Shahla
authors.initials: S
authors.lastname: Masood
mesh_terms: D001943:Breast Neoplasms / Q000145:classification* / Q000473:pathology / Q000628:therapy*; D003695:Delivery of Health Care / Q000639:trends*; D019008:Drug Resistance, Neoplasm; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D008495:Medical Oncology / Q000639:trends*; D009367:Neoplasm Staging; D057285:Precision Medicine / Q000639:trends*; D012307:Risk Factors
keywords: breast cancer subtypes; molecular characterization; personalized medicine